The technological foundation supporting the growth of the medical cannabis market

As the medical cannabis market gains solidity and regulatory debate advances, a silent technological transformation has been shaping the backstage of this new scenario. 

Away from the spotlight, D9Tech has been establishing itself as the foundation that ensures efficiency, predictability, and security for the sustainable growth of the ecosystem in Brazil.
 

Founded in 2023, the Brazilian health-fintech has become an essential infrastructure for the sector. Its solutions have already supported the care of over 40,000 patients and drive 25% of the operations of medical cannabis importers in the country (RDC 660).

“We never sought noise. We seek real impact. Our role is to be the layer that ensures the sector operates with safety, efficiency, and governance,” highlights Gabriel Camargo, neuroscientist and CEO of D9Tech.

With significant results, companies using D9Tech's solutions report gains of up to 80% in operational efficiency, significantly reducing errors, time, and costs, advancements that establish the company as a reference in technology and innovation applied to health.

Integrated solutions connecting the ecosystem

D9Tech offers a portfolio of solutions that meet the main demands of the medical cannabis chain:

D9Pro ERP: complete management system, with flow automation, helpdesk, integrated KYC, intelligent reports, document management, and logistics integration, all to optimize processes and ensure professionalism in operations.

D9Pay: proprietary payment solution, integrated with ERP and the sector, with competitive rates and a focus on compliance, financial automation, and risk mitigation.

The company is also moving towards the clinical end, with D9Med, a platform aimed at prescribing doctors, offering digital prescription, telemedicine, and intelligent tools for managing the therapeutic journey safely, intuitively, and integrated.
 

“In the early days of the market, entrepreneurship was like building a house and still needing to make the brick itself. D9Tech emerges to change this scenario, delivering structured and connected blocks so that the sector can grow with efficiency and a focus on patient care,” explains Camargo.

Responsible innovation and future vision

As the sector advances to a more regulated phase, D9Tech directs its efforts towards compliance infrastructure, pharmacovigilance, and applied intelligence, preparing for the ethical and strategic use of clinical data and artificial intelligence.
“The next era will be guided by intelligence and governance. Our role is to build this foundation with seriousness and responsibility,” reinforces the CEO.

Acting discreetly and consistently, D9Tech supports importers, associations, clinics, doctors, marketplaces, and compounding pharmacies, strengthening each link in the chain and promoting sustainable and professionalized growth for the sector.